Doctor profile · Federal record

Dr. Mark Millard, M.D.

Pulmonary Disease Physician (CMS: Pulmonary Disease) · Dallas, TX

  • NPI 1609877737
  • Accepts Medicare
  • 50 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
4004 Worth St, Suite 300
Dallas, TX 75246
(214) 820-3500
fax (214) 820-9799
Mailing address
3600 Gaston Ave, Lb-143
Dallas, TX 75246

Credentials & registration

NPPES · NUCC
NPI registered
August 2005 — 21 yrs on file
Profile last updated
July 5, 2023
Year of graduation
1976 — 50 yrs since
Specialty taxonomy
207RP1001X — NUCC code
State license (1)
Texas #G0775
Medicaid
TX #120516304

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1609877737. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
758
Distinct HCPCS
10
Medicare allowed
$34,937
HCPCS Description Services Patients Avg allowed
94010 Test to measure expiratory airflow and volume 235 161 $8
99214 Established patient office or other outpatient visit, 30-39 minutes 213 154 $96
94729 Test to examine how well the lungs exchange gases 80 68 $9
94618 Test for exercise-induced lung stress 52 39 $22
94060 Test to measure expiratory airflow and volume changes before and after medication administration 51 48 $10
94726 Test to determine lung volumes using sensors 35 34 $12
99215 Established patient office or other outpatient visit, 40-54 minutes 34 29 $141
94621 Test for exercise-induced heart and lung stress 30 30 $65
99205 New patient office or other outpatient visit, 60-74 minutes 16 16 $178
94070 Test to measure lung airway sensitivity 12 11 $27

In context: peer comparison

Among 48 peers in this city , average services per provider: 88. This provider delivers 8.6× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,183
Transactions
51
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 17 $280.44
Regeneron Healthcare Solutions, Inc. 6 $194.14
GlaxoSmithKline, LLC. 10 $178.83
United Therapeutics Corporation 1 $139.06
Insmed, Inc. 4 $98.97
GENZYME CORPORATION 3 $86.68
Grifols USA, LLC 3 $69.91
Merck Sharp & Dohme LLC 3 $58.90
Vifor Pharma, Inc. 1 $21.88
Itamar Medical Inc 1 $20.83
ANI Pharmaceuticals, Inc. 1 $20.47
Philips North America LLC 1 $13.37

By nature of payment

Food and Beverage
$1,183

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,404
Patients
365
Total drug cost
$687,726
Drug Type Claims Patients Total cost
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) Brand 276 53 $243,897
Azelastine Hcl Generic 169 59 $6,618
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 137 51 $4,623
Spiriva Respimat (Tiotropium Bromide) Brand 109 19 $77,923
Fluticasone Propionate Generic 103 35 $1,810
Breo Ellipta (Fluticasone/Vilanterol) Brand 90 21 $49,496
Fluticasone-Salmeterol (Fluticasone Propion/Salmeterol) Brand 89 18 $17,703
Symbicort (Budesonide/Formoterol Fumarate) Brand 76 27 $32,830
Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) Brand 68 12 $47,262
Prednisone Generic 63 37 $213

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Mark Millard's medical specialty?
Dr. Mark Millard practices Pulmonary Disease Physician in Dallas, TX.
Where does Dr. Mark Millard practice?
Dr. Mark Millard practices at 4004 Worth St, Dallas, TX 75246. Office phone: 2148203500.
What is Dr. Mark Millard's NPI?
Dr. Mark Millard's National Provider Identifier (NPI) is 1609877737, issued by NPPES.
Does Dr. Mark Millard accept Medicare assignment?
Yes. Dr. Mark Millard accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Millard commonly perform?
Top Medicare-reported procedures in 2023: Test to measure expiratory airflow and volume (HCPCS 94010); Established patient office or other outpatient visit (HCPCS 99214); Test to examine how well the lungs exchange gases (HCPCS 94729). Source: CMS Medicare Physician & Other Practitioners file.